Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Onco...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Criscitiello C, Viale G, Curigliano G, Goldhirsch A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/cf53a45a28df41ae9d9237ca439bd00c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:cf53a45a28df41ae9d9237ca439bd00c
record_format	dspace
spelling	oai:doaj.org-article:cf53a45a28df41ae9d9237ca439bd00c2021-12-02T04:49:43ZProfile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]1179-1314https://doaj.org/article/cf53a45a28df41ae9d9237ca439bd00c2018-03-01T00:00:00Zhttps://www.dovepress.com/corrigendum-bctt-166117-profile-of-buparlisib-and-its-potential-i-peer-reviewed-article-BCTThttps://doaj.org/toc/1179-1314Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Oncology, Milan, Italy.It should be Department of Oncology and Hemato-Oncology,Division of Early Drug Development for Innovative Therapy,University of Milan, European Institute of Oncology, Milan,Italy.Read the original articleCriscitiello CViale GCurigliano GGoldhirsch ADove Medical PressarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENBreast Cancer: Targets and Therapy, Vol Volume 10, Pp 51-52 (2018)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Criscitiello C Viale G Curigliano G Goldhirsch A Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
description	Criscitiello C, Viale G, Curigliano G, et al. Profile ofbuparlisib and its potential in the treatment of breast cancer:evidence to date. Breast Cancer (Dove Med Press).2018;10:23–29.On page 23, Giuseppe Curigliano’s affiliation was incorrcectlylisted as European Institute of Oncology, Milan, Italy.It should be Department of Oncology and Hemato-Oncology,Division of Early Drug Development for Innovative Therapy,University of Milan, European Institute of Oncology, Milan,Italy.Read the original article
format	article
author	Criscitiello C Viale G Curigliano G Goldhirsch A
author_facet	Criscitiello C Viale G Curigliano G Goldhirsch A
author_sort	Criscitiello C
title	Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_short	Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_full	Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_fullStr	Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_full_unstemmed	Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]
title_sort	profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [corrigendum]
publisher	Dove Medical Press
publishDate	2018
url	https://doaj.org/article/cf53a45a28df41ae9d9237ca439bd00c
work_keys_str_mv	AT criscitielloc profileofbuparlisibanditspotentialinthetreatmentofbreastcancerevidencetodatecorrigendum AT vialeg profileofbuparlisibanditspotentialinthetreatmentofbreastcancerevidencetodatecorrigendum AT curiglianog profileofbuparlisibanditspotentialinthetreatmentofbreastcancerevidencetodatecorrigendum AT goldhirscha profileofbuparlisibanditspotentialinthetreatmentofbreastcancerevidencetodatecorrigendum
_version_	1718401035200888832

Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum]

Ejemplares similares